Moderna Inc Capital Reinvestment Ratio
Moderna Inc capital reinvestment ratio. Moderna Inc (MRNA) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($951.00 Million) in capital expenditures ($39.00 Million). See how much free cash does Moderna Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Moderna Inc (2016–2022)
Capital reinvestment ratio of Moderna Inc from 2016 to 2022. This chart tracks Moderna Inc's Capital Reinvestment Ratio across 4 annual periods. See Moderna Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Moderna Inc Capital Reinvestment Ratio by Year (2016–2022)
Moderna Inc capital reinvestment ratio by year from 2016 to 2022. For the full cash flow conversion analysis, see Moderna Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.08x | $4.98 Billion | $400.00 Million | ▲ +285.1% |
| 2021 | 0.02x | $13.62 Billion | $284.00 Million | ▼ -37.3% |
| 2020 | 0.03x | $2.03 Billion | $67.45 Million | ▼ -93.3% |
| 2016 | 0.50x | $66.73 Million | $33.14 Million | — |